-21.7%
MRNA vs CTAS
+108.9%
-130.6%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CTAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.1% | -4.8% | -4.8% |
| 7D | -20.9% | -2.1% | -18.8% | -19.9% |
| 30D | -13.3% | +4.8% | -18.1% | -15.9% |
| 3M | +212.6% | +11.6% | +201.0% | +193.6% |
| 6M | +309.0% | +27.8% | +281.2% | +253.9% |
| YTD | +567.3% | +19.2% | +548.1% | +495.1% |
| 1Y | +689.7% | +21.9% | +667.8% | +595.9% |
| 3Y | +157.4% | +66.3% | +91.1% | +66.1% |
| 5Y | -21.7% | +110.2% | -131.9% | -64.9% |
| All | -21.7% | +108.9% | -130.6% | -64.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CTAS.
Daily Out/Under-Performance
Portfolio return minus CTAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CTAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CTAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling